Tackling Pakistan's High Smoking Rate Through Nicotine Pouches

Regulations by 2FIRSTS.ai
May.14.2024
Tackling Pakistan's High Smoking Rate Through Nicotine Pouches
Pakistan's smoking rate of 24% poses a public health crisis, but nicotine pouches offer a promising alternative according to PakObserver.

According to the Pakistani media PakObserver, on May 14, Pakistan's smoking rate is a staggering 24%, with symptoms of addiction to smoking already posing a major challenge to public health and economic development. Smoking-related diseases, including heart disease, chronic obstructive pulmonary disease, lung cancer, stroke, and tuberculosis, will undoubtedly put even greater pressure on the already burdened healthcare system, leading to population decrease and severe economic losses.

 

Despite the efforts of the Pakistani government to control smoking, they have still not been able to achieve their smoking control goals. The current methods of smoking control are clearly outdated and ineffective. However, a glimmer of hope is emerging in the form of Tobacco Harm Reduction (THR), with oral nicotine pouches being seen as a viable alternative.

 

According to the latest global report "Incorporating Harm Reduction into Tobacco Control," intervention measures such as promoting nicotine pouches have the potential to effectively reduce premature deaths caused by smoking. By using nicotine pouches, consumers can satisfy their craving for nicotine without being exposed to harmful substances produced by combustion.

 

If nicotine pouches were to be widely accepted by the population of Pakistan, the current alarming smoking rate of 34.3% would decrease to 8% by 2045, and further drop to 5% by 2060. This would have a significant impact on the current smoking-related mortality rate, reducing it from the current 163,000 deaths per year to 114,000 by 2045, and even further to 76,000 by 2060. Additionally, the economic burden of smoking in Pakistan is as high as Rs 615.07 billion (approximately $3.85 billion), accounting for 1.6% of the country's GDP.

 

However, moving towards a smoke-free future is not without difficulties. Despite evidence proving the effectiveness of reduced harm products in reducing tobacco-related harm, policymakers are cautious about implementing them. To address this issue and reduce smoking rates, multiple measures must be taken. Additionally, taxes on Tobacco Harm Reduction (THR) alternatives should be reduced to support their availability and accessibility.

 

Promoting alternatives like nicotine pouches can help alleviate Pakistan's economic burden by reducing and treating smoking-related health care costs. By encouraging the adoption of these smokeless products, policymakers can redirect resources to other areas of the economy. Including nicotine pouches as an option can help smokers satisfy their nicotine cravings while avoiding the harmful substances produced by combustion.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor DeSantis Expands TANF Restrictions, Blocking Welfare Benefits From Buying Tobacco and Vapes
Florida Governor Ron DeSantis announced an expansion of Temporary Assistance for Needy Families (TANF) restrictions that would prohibit Electronic Benefit Transfer (EBT) funds from being used to purchase tobacco and vaping products. The state will amend its TANF State Plan and submit the changes for federal approval. Florida officials said the restrictions would not affect eligibility for temporary cash assistance or the amount of benefits received, but would change how funds can be spent.
Aug.25
Gallery | InterTabac 2026 Opens as VAPORESSO, SKE, GREENTANK, GEEK BAR and Other Brands Take the Floor
Gallery | InterTabac 2026 Opens as VAPORESSO, SKE, GREENTANK, GEEK BAR and Other Brands Take the Floor
InterTabac 2026 opened in Dortmund, Germany, on September 15 alongside NUBIZ and InterSupply. According to the latest figures released by the organizer, the three trade shows bring together around 750 exhibitors from 64 countries. On site, 2Firsts observed vaping and related brands including VAPORESSO, DOJO, SKE, GREENTANK, GEEK BAR, HQD and ELUX.
Special Report
Sep.15
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
California Lawmakers Pass Disposable Nicotine Vape Ban, With Sales Prohibition Set for 2028
According to CBS Los Angeles on August 27, 2026, California lawmakers have passed Assembly Bill 762, which would phase out disposable, battery-embedded nicotine vapes in the state. If signed by Governor Gavin Newsom, manufacturing and importation of the covered products would be prohibited beginning January 1, 2027, followed by a sales ban on January 1, 2028. Driven primarily by concerns over electronic waste, lithium-battery fires and environmental pollution, the legislation would further shift California’s legal vape market toward rechargeable, refillable or replaceable-pod devices.
Aug.28
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
2Firsts Compliance Solutions Hosts PMTA Briefing on FDA Review Signals After JUUL2 Authorization
Following recent FDA authorizations for JUUL2 and ZYN ULTRA, 2Firsts Compliance Solutions held an online PMTA briefing on Sept. 4 to examine what the decisions may signal about review efficiency, scientific evidence and U.S. market access. Nearly 30 participants from brands, manufacturers, compliance service providers and investment firms joined the discussion.
2Firsts Events
Sep.06
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22